Valuation: Ipsen

Market Cap 1.4TCr 1.6TCr 1.29TCr 1.2TCr 2.28TCr 1,52600Cr 2.31TCr 15TCr 6.01TCr 75TCr 6.02TCr 5.89TCr 2,58500Cr P/E 2026 *
15.6x
P/E 2027 * 15.3x
Enterprise Value 1.26TCr 1.44TCr 1.16TCr 1.08TCr 2.05TCr 1,37200Cr 2.08TCr 14TCr 5.4TCr 67TCr 5.41TCr 5.29TCr 2,32400Cr EV / Sales 2026 *
2.95x
EV / Sales 2027 * 2.59x
Free-Float
40.65%
Yield 2026 *
0.84%
Yield 2027 * 0.87%
1 day-0.70%
1 week+2.73%
Current month+0.41%
1 month+7.41%
3 months+3.42%
6 months+40.08%
Current year+42.44%
1 week 164.8
Extreme 164.8
172.7
1 month 152.7
Extreme 152.7
172.7
Current year 116
Extreme 116
173.5
1 year 101.6
Extreme 101.6
173.5
3 years 87.95
Extreme 87.95
173.5
5 years 77
Extreme 77
173.5
10 years 34.2
Extreme 34.2
173.5
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Date Insider Type Main position Quantity % Market Cap.
01/06Fiscal year

Chief Executive Officer

-26,583 0.0317%
27/05Sell

Chief Executive Officer

-1,000 0.0012%
25/02Sell

Chairman

3,800 0.0045%
Change 5-day change 1-year change 3-year change Capi.($)
-0.70%+2.73%+65.37%+55.50% 1.6TCr
-1.03%-2.08%+55.83%+160.00% 1,08200Cr
-2.04%-0.14%+66.25%+59.74% 63TCr
-2.10%+0.61%+36.36%+86.41% 46TCr
-2.79%+1.37%+31.00%+23.05% 34TCr
-2.93%-1.65%+37.62%+36.15% 30TCr
-2.24%-0.87%+28.16%+42.69% 29TCr
-1.77%+1.97%-27.22%-40.66% 22TCr
-2.89%+0.77%+24.02%+62.94% 20TCr
-1.95%+1.99%+15.26%+68.99% 16TCr
Average -2.04%+4.52%+33.26%+55.48% 37.08TCr
Weighted average by Cap. -1.93%+5.43%+40.84%+80.30%

Financials

2026 *2027 *
Net sales 426.51Cr 487.88Cr 391.96Cr 365.35Cr 692.97Cr 46TCr 703.48Cr 4.71TCr 1.83TCr 23TCr 1.83TCr 1.79TCr 79TCr 447.94Cr 512.4Cr 411.66Cr 383.71Cr 727.79Cr 49TCr 738.83Cr 4.94TCr 1.92TCr 24TCr 1.92TCr 1.88TCr 83TCr
Net income 94Cr 107.49Cr 86Cr 80Cr 152.68Cr 10TCr 154.99Cr 1.04TCr 403.03Cr 5.03TCr 403.49Cr 394.82Cr 17TCr 95Cr 108.5Cr 87Cr 81Cr 154.11Cr 10TCr 156.45Cr 1.05TCr 406.81Cr 5.08TCr 407.27Cr 398.52Cr 17TCr
Net Debt -141.94Cr -162.37Cr -130.45Cr -121.59Cr -230.62Cr -15TCr -234.12Cr -1.57TCr -608.79Cr -7.6TCr -609.47Cr -596.38Cr -26TCr -241.35Cr -276.08Cr -221.8Cr -206.74Cr -392.14Cr -26TCr -398.08Cr -2.66TCr -1.04TCr -13TCr -1.04TCr -1.01TCr -45TCr
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
06/26/06 169.50 -0.70% 80,079
03/26/03 €170.70 -0.23% 68,410
02/26/02 €171.10 +3.20% 1,34,415
01/26/01 €165.80 -1.78% 1,22,377
30/26/30 €168.80 +2.30% 1,28,092
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
170.70EUR
Average target price
161.33EUR
Spread / Average Target
-5.49%

Quarterly revenue - Rate of surprise